Regeneron Pharmaceuticals (REGN) Net Income (2009 - 2026)
Regeneron Pharmaceuticals' Net Income was $1.3 billion in Q2 2026, down 6.8% from $1.39 billion a year earlier but up 78.3% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Net Income (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Regeneron Pharmaceuticals' Net Income was $4.33 billion through Jun 30, 2026, down 2.9% year-over-year; for FY2025, it came in at $4.5 billion, up 2.1% from FY2024.
- Net Income shows a five-year compound annual growth rate of 5.1% (FY2020 to FY2025).
- In earlier years, Net Income was $4.41 billion in FY2024 (+11.6%), $3.95 billion in FY2023 (-8.9%), $4.34 billion in FY2022 (-46.3%) and $8.08 billion in FY2021 (+129.9%).
- Quarterly Net Income has moved between $722 million (Q1 2024) and $2.23 billion (Q4 2021) over five years.
- Compared with a year earlier, Net Income has declined for three straight quarters, with growth averaging 0.7% over the last eight quarters.
- The best year-over-year quarter for Net Income over five years was Q4 2021 (growth of 94.0%); the worst was Q2 2022 (a decline of 72.5%).
- Per Business Quant data, REGN's Net Income in the three quarters before Q2 2026 was $727.2 million (Q1 2026), $844.6 million (Q4 2025) and $1.46 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 1.30 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.30 Bn |
| Mar 31, 2026 | 727.20 Mn |
| Dec 31, 2025 | 844.60 Mn |
| Sep 30, 2025 | 1.46 Bn |
| Jun 30, 2025 | 1.39 Bn |
| Mar 31, 2025 | 808.70 Mn |
| Dec 31, 2024 | 917.70 Mn |
| Sep 30, 2024 | 1.34 Bn |
| Jun 30, 2024 | 1.43 Bn |
| Mar 31, 2024 | 722.00 Mn |
| Dec 31, 2023 | 1.16 Bn |
| Sep 30, 2023 | 1.01 Bn |
| Jun 30, 2023 | 968.40 Mn |
| Mar 31, 2023 | 817.80 Mn |
| Dec 31, 2022 | 1.20 Bn |
| Sep 30, 2022 | 1.32 Bn |
| Jun 30, 2022 | 852.10 Mn |
| Mar 31, 2022 | 973.50 Mn |
| Dec 31, 2021 | 2.23 Bn |
| Sep 30, 2021 | 1.63 Bn |
API Access
Regeneron Pharmaceuticals Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();